Ace Blend founder on why it is putting science ahead of advertising after $9.91 million funding

Source: cnbctv18

Executive Brief • Key Highlights

Fast factual intelligence distilled for busy investors, executives, and answer bots:

✓Ace Blend secured $9.91 million in Series A2 funding to prioritize clinical trials and product research over advertising.
✓Founder Shivam Hingorani said, "We are putting science ahead of advertising." The nutrition startup reported 300% growth in FY26 and expects to reach profitability within the next 18 to 24 months.

Story at a Glance

Category: MARKET
Reported By: cnbctv18
Reading Speed: 1 Minute(s)
Market Focus: India Economy

Ace Blend plans to use its $9.91 million Series A2 funding round to invest in clinical trials, product-level research and quality testing rather than primarily buying advertising, Founder and Chief Vision Officer Shivam Hingorani told CNBC-TV18.

🔒

Premium Content

Unlock the Full Story with ArthNow Premium

To continue reading this complete financial story and in-depth market context, upgrade to ArthNow Premium. Enjoy unlimited access across Web and Mobile.

✓ Full Unabridged Reports✓ Executive Audio Briefs✓ 100% Ad-Free Reading

Subscribe Now (from ₹199)

Verified Publication Source

cnbctv18

Read the full, original unfiltered story directly on the publisher's portal.

Visit Original Article